Amarin Corporation plc AMRN was a big mover last session, as the company saw its shares rise over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading in a …
Biotech stock Amarin Corporation plc (ADR) (NASDAQ:AMRN) has been quite the conversation piece lately, and for good reason. Following a major analyst upgrade from HC Wainwright a couple weeks ago, we saw tremendous gains in …
Even more importantly, this was an $8 and $9 stock the prior week. It seems hard to get excited here after such a big price drop this past week, but those calls were made that still implied high upside. On Thursday, Amarin Corp. PLC …
Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately. BEDMINSTER, N.J., and DUBLIN, Ireland, April 23, 2018-- Amarin Corporation plc, a biopharmaceutical company …
Despite rising 8 percent in 2012, by most accounts it was a very disappointing year for Amarin (NASDAQ: AMRN) shareholders. After receiving FDA approval for Vascepa mid-year, and seeing its stock rise as much as 113%, shares …
On CNBC's Mad Money, Jim Cramer said during the Lightning Round that Amarin (NASDAQ: AMRN) is a “speculative …
Up 24% pre-market, Amarin stock (AMRN) is looking like it’s hit the right mark, as the FDA considers a study request that could mean a big boom for the pharmaceutical. AMRN stock is set to boom today as the good news trickles out. The …
Amarin Corp. (NASDAQ: AMRN) started as Buy with $20 target at Citigroup ... Cardinal Financial Corp. (NASDAQ: …
DUBLIN (AP) _ Amarin Corp. PLC (AMRN) on Wednesday reported a loss of $24.1 million in its first quarter. The Dublin-based company said it had a loss of 8 cents per share. Losses, adjusted for stock option expense, were 7 cents per …